RxDoctor Payments Data

Daniel Wilkes, DPM

Primary Podiatric Medicine · Mount Airy, NCNPI 1932764016

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,138 of the $3,351 with a category attached, or 63.8%. 20 manufacturers reported payments, led by Stryker at 25.9% of the total. Reporting peaked in 2022 at $1,703 and has fallen 77.4% since, to $385 in 2025.

$3,351in general payments, 2019–2025

Across 66 payments — averaging $50.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$867
  • Medical Device Business Services, Inc.$753
  • Convatec Inc.$418
  • Davol Inc.$291
  • Vertex$181
  • Organogenesis Inc.$174
  • plus $669 from 14 others

What the payments were for

  • Travel & lodging$1,21336%
  • Food & beverage$2,13864%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,351 in reported general payments places this provider in the 75th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$364,810
Medicare patients
261
Services billed
1,681

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin37$647
Ciclopirox15$383
Gabapentin23$285
Cephalexin37$181
Doxycycline Hyclate20$147
Methylprednisolone14$139
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$129
Mupirocin16$122
Fluconazole20$121
Ciprofloxacin Hcl11$106
Silver Sulfadiazine14$102
Meloxicam38$49

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Mount Airy

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →